RAS genes act downstream of KIT in the RTK signaling pathway, therefore the synthetically lethal relationship between KRAS/NRAS and WT1 might also translate to the mutually exclusive KIT-WT1 candidate in AML. The gene discussed is KRAS; the disease is acute myeloid leukemia.